Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor

Bioorg Chem. 2024 Feb:143:106998. doi: 10.1016/j.bioorg.2023.106998. Epub 2023 Nov 28.

Abstract

Androgen receptor (AR) plays a crucial role in various physiological processes. Dysregulation of AR signaling has been implicated in several diseases, such as prostate cancer and androgenetic alopecia. Therefore, the development of drugs that specifically target AR has gained significant attention in the field of drug discovery. This review provides an overview of the synthetic routes of clinically approved small molecule drugs targeting AR and discusses the clinical applications of these drugs in the treatment of AR-related diseases. The review also highlights the challenges and future perspectives in this field, including the need for improved drug design and the exploration of novel therapeutic targets. Through an integrated analysis of the therapeutic applications, synthetic methodologies, and mechanisms of action associated with these approved drugs, this review facilitates a holistic understanding of the versatile roles and therapeutic potential of AR-targeted interventions. Overall, this comprehensive review serves as a valuable resource for medicinal chemists interested in the development of small-molecule drugs targeting AR.

Keywords: Androgen receptor; Applications; Drugs; Small-molecule; Synthesis.

Publication types

  • Review

MeSH terms

  • Drug Design
  • Drug Discovery
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Receptors, Androgen*
  • Signal Transduction

Substances

  • Receptors, Androgen